Raspberry Pi shares jump as full year results beat expectations

Raspberry Pi announced its FY 2024 results, showing a modest 2% decline in revenue to $259.5 million but a more substantial 57% drop in profit before tax to $16.3 million for its first year as a London-listed company.

However, the results were ahead of analyst expectations, and shares rose over 8%, helped by a bullish outlook for the year ahead.

Eben Upton, CEO of Raspberry Pi, was upbeat about the company’s prospects, saying: “I am confident that we will continue to see gradual improvements in end-demand during the current year and increased traction with direct-to-OEM engagement, effectively complementing our reseller and licensee channels.”

The computing firm weathered an industry-wide destocking phase following an exceptional 2023 performance. Unit sales fell by 5% to 7 million devices, while the company significantly expanded its product lineup with 22 new releases—a 267% increase from the previous year.

Despite these headwinds, the company projects a positive outlook for 2025, pointing to normalised channel inventory and strengthening end-market demand through Q4.

Raspberry Pi expects gross profit per unit to increase year-on-year, supported by secured memory supply through Q4. Management expressed confidence in “solid and sustainable sales growth” for 2025, with several promising OEM customer discussions potentially contributing significantly to performance in 2026 and beyond.

“Raspberry Pi has snuck over the line in narrowly beating analysts’ estimates in what is the company’s first full year report since its IPO. The bar was set pretty high given 2023 was a very strong year and inventory issues were a drag on profits for a large part of the year,” said Adam Vettese, market analyst at eToro.

“Sales of the flagship Raspberry Pi5 have been key to helping the new kids on the block establish a foothold in a market dominated by some very heavy hitters. Expanding their reach through strategic partnerships with a now boosted profile post-IPO seems to be working well.”

How to Pass a Prop Trading Evaluation

Prop trading firms give traders access to company capital to trade in financial markets. In return, traders must prove they can manage risk and generate profits. Passing a prop trading evaluation is the first step to getting funded, but many traders struggle to meet the required standards.  

This guide will break down the key areas to focus on so you can pass your evaluation with confidence. 

1. Understand the Rules Before You Start 

Each prop firm has different rules and objectives, with some focusing on profit targets, while others set strict risk limits. Reading through the terms carefully prevents mistakes that could lead to failure. Breaking any rule often leads to immediate disqualification. Taking time to understand the rules can prevent unnecessary losses and frustration. 

Most firms set requirements such as a profit target, a maximum daily loss limit, an overall drawdown limit, and consistency in trading. Knowing these in advance helps avoid mistakes that could fail the evaluation. 

2. Trade With a Strategy, Not Impulses 

A solid trading strategy is the foundation of success. Entering random trades in the hope of hitting the profit target rarely works. Instead, having a structured approach increases the chances of passing the evaluation. 

A good trading strategy includes: 

  • Clear entry and exit points 
  • Risk-reward ratios (e.g., aiming for 2:1 or better) 
  • Defined stop-loss and take-profit levels 
  • Trading in liquid markets with tight spreads 

Backtesting the strategy on a trading platform helps identify strengths and weaknesses before the evaluation begins. 

3. Keep Risk Low and Steady 

Most prop firms want to see consistency rather than quick profits, meaning you need to manage risk properly to reduce the chances of hitting loss limits too soon. Some traders fail because they try to reach the profit target too quickly. Taking controlled risks and aiming for steady gains is the better approach. 

Risking no more than 1-2% per trade, using stop-loss orders, and avoiding revenge trading are all ways to keep risk manageable. Following these principles makes it easier to pass without unnecessary losses. 

4. Trade Within the Firm’s Rules and Conditions 

Some firms restrict trading on specific assets, during news events, or at certain hours. Ignoring these restrictions can lead to automatic disqualification. 

To avoid issues: 

  • Trade only approved markets and assets 
  • Avoid high-impact news events if restricted 
  • Follow lot size and leverage rules 

Checking the firm’s guidelines before placing trades helps avoid unnecessary rule violations. 

5. Stay Disciplined and Avoid Emotional Trading 

Discipline separates successful traders from those who fail evaluations. Many traders struggle because they make emotional decisions instead of sticking to their plan. 

Common mistakes include increasing position size after a loss, closing trades too early out of fear, and overtrading to chase profits. Sticking to a plan and keeping emotions out of trading prevents costly errors. Taking breaks after a losing streak also helps reset focus. 

6. Manage Drawdowns Wisely 

Every trader faces losses, but how those losses are handled matters. Hitting the maximum drawdown limit usually results in instant failure. 

To stay within limits: 

  • Set a daily loss cap lower than the firm’s maximum 
  • Avoid large trades after a losing streak 
  • Focus on preserving capital rather than forcing trades 

Surviving bad days keeps the account safe and allows time to recover losses later. 

7. Use a Trading Platform That Suits You 

A good trading platform makes passing an evaluation easier and some prop firms provide their own platforms, while others allow traders to choose. 

A reliable platform should have fast execution speeds, low spreads and commissions, risk management tools, and charting features. Practising on the same platform before the evaluation helps traders get comfortable and avoid execution mistakes. 

8. Treat the Evaluation Like a Live Account 

Some traders take unnecessary risks because they view the evaluation as a practice run. While it’s not real money, passing means gaining access to live funds. Treating the evaluation with the same mindset as a funded account increases the chances of success. 

  • Stick to the same strategies you plan to use later 
  • Follow proper risk management at all times 
  • Keep a trading journal to track progress and refine strategies 

Taking the evaluation seriously helps build habits that will be useful when trading with real capital. 

Passing Your Evaluation and Getting Started Today 

Passing a prop trading evaluation requires more than just making profits. Sticking to a structured plan, managing risk, and following firm rules are just as important. Many traders fail due to impatience, overtrading, or ignoring risk limits. 

A calm and disciplined approach gives the best chance of passing. Taking the time to understand the rules, keeping emotions under control, and treating the evaluation like a real account will set traders up for success. 

Trading with a clear plan, controlled risk, and the right mindset makes the path to funded trading much smoother. 

Greencore snaps up Bakkavor to create £4bn food giant

Sandwich maker Greencore and chilled foods specialist Bakkavor have struck a deal to create a food giant which will have over £4bn in combined revenues.

Greencore announced on Wednesday that it had reached an agreement in principle with Bakkavovor for an all share offer to be satisfied by a mix of shares and cash.

The 200p per share deal would value Bakkavor at £1.2bn on a fully diluted basis, and represent a 33% premium to Bakkavor’s share price of 151p as of the close 13th March when Greencore first made a move.

Today’s agreement follows a couple of earlier offers by Greencore that Bakkavor said undervalued them.

Bakkavor shares were 6% higher at 189p at the time of writing on Wednesday.

The deal has clear benefits. The newly combined entity would have a much bigger coverage of the convenience food market, and merging their supply chains will produce efficiencies across the group. 

Greencore’s strength in sandwiches will be complemented by a broad range of new products within the Bakkavor fold, including pizzas, soups, and salads.

The tie-up will also deepen Greencore’s geographical reach with additional exposure to the US and China.

Although the offer is exciting from an M&A perspective, it further highlights the vulnerabilities of UK-listed companies to takeover approaches due to their low valuation.

FTSE 100 bounces back from ‘Liberation Day’ fears, Kingfisher continues recovery

The FTSE 100 was firmly higher on Tuesday as investors buckled up for Donald Trump’s ‘Liberation Day’ of economically damaging trade tariffs set to come into force tomorrow.

London’s leading index was 0.6% higher at the time of writing.

US indices reversed early losses yesterday to finish the session overnight in positive territory, which boosted European equities on Tuesday as bargain hunters stepped into beaten-down names across European indices.

“The fact the S&P 500 ended ahead on Monday, and chunks of Asia and Europe were in positive territory on Tuesday, goes to show that investors have indeed taken time to reflect on the state of events and moved out of panic mood,” said Russ Mould, investment director at AJ Bell.

“The FTSE 100 bounced back with aplomb, rising 0.6% thanks to broad-based strength in the index. While pharma, banks and miners led the way, the fact only four FTSE 100 stocks were in negative territory in early trading suggests investors were fired up and ready to go.”

How equities will react to the confirmation of tariffs on some of America’s closest trading partners tomorrow is anyone’s guess.

There is a school of thought that the recent sell-off in global equities has priced in the impact of tariffs. On the other hand, there’s the complacency argument that the market is properly pricing the impact of tariffs because it still believes tariffs are being used as a negotiating tactic and won’t be around for long. 

Housebuilding shares rose on the latest house price data showing the average UK house price rose 3.9% over the past year, despite remaining unchanged on a month-on-month basis.

“UK house prices rose nearly 4% from last year, according to the Nationwide House Price Index, though growth paused month-to-month and there could be softness to come as buyers accelerated purchases to sidestep expected tax hikes,” explained Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“Despite this short-term slowdown, conditions look promising for a rebound as the year progresses, driven by a strong job market, increasing take-home pay, and the potential for cheaper loans if interest rates come down.”

Persimmon rose 1.3% and Taylor Wimpey added 0.6%.

Banks were higher as investors awaited the next step in the legalities related to the motor financing scandal. Should the courts rule against the banks, they could be on the hook for billions in redress. 

Lloyds shares were 0.7% higher despite it being one of the banks most heavily exposed to potential redress.

“It’s crunch time for UK banks as the supreme court starts hearings this week, looking into motor finance mis-selling and whether car dealers and lenders unlawfully hid commissions from consumers,” Matt Britzman said.

“There’s a lot on the line, especially Lloyds which was the most exposed of the major UK banks. It’ll likely be a few months before the outcome is known, but some estimates suggest it could cost Lloyds around £6bn if it’s forced to refund all motor finance commissions.”

Kingfisher was the top riser, continuing its recovery from a recent selloff. Shares were 2.9% higher.

AIM movers: Strip Tinning battery success and Celadon Pharmaceuticals short of cash

0

Automotive and battery connectors supplier Strip Tinning (LON: STG) is expecting a lower than forecast loss in 2025 because of strong trading in the battery division. This is a higher margin part of the business, and it will help to reduce the EBITDA loss from £1.6m to £900,000. The anticipated lifetime value of an existing US battery connectors client has been raised from £43m to at least £56.8m. The overall market remains difficult, though. A £520,000 R&D tax credit should be received in April and another payment of £250,000 should be received in the second half of 2025. Strip Tinning is on course to make a pre-tax profit in 2027. A grant is being applied for from the Automotive Transformation Fund. Strip Tinning will require more cash to fund growth. The share price rebounded 108.1% to 38.5p, which is the highest it has been since the beginning of the year.

Ironveld (LON: IRON) has returned from suspension after reporting annual results for the year to June 2024 and interims to December 2024. Net cash was £1.31m at the end of December 2024. Ironveld has increased its stake in the DMS Magnetite project from 25% to 50%. First commercial production should be in 2025. The share price increased 11.7% to 0.043p.

Cleaner fuels developer Quadrise (LON: QED) has secured services supply agreement with MAC2 for trials on the MSC Leandra V, which should commence in the current quarter of 2025. The tests could take up to eight months. The share price is 9.29% higher at 4.705p.

Kazera Global (LON: KZG) says investee company Whale Head Minerals has made its first sale of 10,000 tonnes of heavy mineral sands to Fujax South Africa, which is more than the expected 6,000 tonnes.  The share price improved 9.09% to 1.5p.

North Sea oil and gas producer Serica Energy (LON: SQZ) reported 2024 figures with higher oil prices only partly offsetting a reduced gas price and lower production. Revenues fell from a pro forma £917m to £727m, while pre-tax profit declined from £380.4m to £160.5m. Net cash of £99m was turned into net debt of £83m. The final dividend was reduced from 14p/share to 10p/share. The share price rose 7.61% to 144.2p.

FALLERS

Yesterday afternoon, Celadon Pharmaceuticals (LON: CEL) said it has still not received funds following its draw down request from either of its credit facilities. The company is talking to other finance providers. There is support from creditors to enable the cannabis medicines developer to continue to trade in April, but cash is required. The share price slumped 42.8% to 3.5p.

Aquaculture company Benchmark (LON: BMK) has notified Nordic Trustee that it will exercise the call option to redeem all outstanding senior unsecured bonds. The repayment will be at 101.482% of the nominal amount. This follows completion of the disposal of the genetics business. The share price fell 17.2% to 21.2p.

Drug discovery company ImmuPharma (LON: IMM) has agreed to extend the period of warrants in Aquis-quoted skincare technology developer Incanthera (LON: INC). The 7.27 million warrants are exercisable at 9.5p each – the current share price is 9p – and they will be extended until the end of September. ImmuPharma will pay Incanthera a profit share of 30% of the difference between exercise and market prices. Incanthera has agreed to pay creditors £380,000 in shares at 8.5p each. The ImmuPharma share price dipped 5.57% to 2.88p.

Travis Perkins shares plummet as profits sink

The difficulties faced by the construction industry are well-documented and today, are clearly visible in Travis Perkins’s full-year results.

Volumes were weaker as builders held off on new construction projects. However, the real blow for Travis Perkins’ financials is that after years of price inflation, the company is experiencing price deflation, especially in timber goods.

This is welcome news for the construction industry as a whole, but increased competitiveness in the merchanting business means Travis Perkins has to pass on the lower prices to their customers.

The result was a 98% drop in operating profits for the year and 9% drop in Travis Perkins shares as of the time of writing on Tuesday.

“Travis Perkins’ full-year results make for grim reading, with the company reporting a 23% drop in annual profits. Shareholders cannot seem to catch a break as Travis Perkins shares have sunk to a 16-year low in 2025, hammering home the difficulties the company is facing,” said Mark Crouch, market analyst at eToro.

“The building materials supplier attributes the disappointing performance to a slow recovery in the construction sector, as the UK economy continues to struggle. With interest rates remaining stubbornly fixed in place, uncertainty is weighing heavily on both investors and consumers, leaving them hesitant to act.”

The company’s outlook underlines how desperate they are for interest rate cuts. Unfortunately, the Bank of England seems to have other ideas, and we may only see one or two more in the rest of 2025.

Travis Perkins said: ‘the pace and rate of an overall recovery in construction activity levels remains uncertain and will likely need further cuts to interest rates and an uplift to consumer confidence levels to stimulate a meaningful increase in demand’.

1Spatial wins contract with Kent County Council

1Spatial, the global leader in Location Master Data Management software, has secured a 12-month contract with Kent County Council worth £0.5 million for its 1Streetworks solution.

This is the third major contract for 1Spatial’s 1Streetworks platform, following significant deals with other councils announced last year. The company seems to be building a head of steam.

The cloud-based SaaS solution pioneers full automation of traffic management plans, diversion routing, and asset inventory lists. Its platform-sharing capabilities allow multiple users to view plans and locations. Implementation requires minimal disruption to existing operational processes.

Kent residents, like many of us across the UK, face substantial disruption from numerous annual road closures. 1Spatial’s solution is designed to reduce this disruption.

The council estimates that using 1Streetworks to review and adjust road closure requests could reduce closures by at least 40%.

“We are delighted to secure our third material contract for 1Streetworks,” said 1Spatial CEO, Claire Milverton.

“We are seeing growing appreciation of the product and its value to customers. Adoption by a second council will help accelerate growing market awareness of the benefits it brings. The Board will continue to focus on executing on the substantial addressable market opportunity.”

1Spatial announced a similar deal with Surrey County Council last year that was worth £1m.

GenIP issues maiden results following AIM IPO

GenIP has released its maiden unaudited results for its first year of operations, outlining early traction and a healthy cash position.

The AIM-listed firm provides solutions to organisations seeking to accelerate the commercialisation of new technological discoveries through AI-enhanced analytics services.

The Generative AI analytics firm generated $144k revenue in the period to 31 December, producing a gross profit of $37k. New services were launched towards the end of the year, with initial orders and associated revenue reported in maiden results reflecting the early stages of their rollout.

GenIP has since announced orders exceeding $400k, suggesting the company’s marketing efforts are having the desired effect. Recent announcements highlight an active approach to winning new clients through event sponsorship and engaging directly with technology transfer professionals.

Material losses were recorded during its first year of operations, but these were mainly the result of the listing process. Costs relating to the AIM IPO and fundraise totalled $896,322, while the total operating loss for the year was $806,815. This implies that much of last year’s overall loss would have been incurred as part of the IPO rather than ongoing costs.

The accounts revealed around $270k in share-based payments to contractors and staff as part of the IPO, which make up a large part of the IPO costs.

This meant GenIP entered 2025 with just under $1m in cash after raising net proceeds of £1.1m from the IPO. Assuming a similar pace of underlying operational cost has been incurred since, the company will be in a healthy position given the level of recent orders.

The company is confident in its growth trajectory and believes it ‘is well-positioned to drive sustainable growth by catering to B2B clients who benefit from repeat usage of GenIP’s services’.

GenIP’s customers include some of the world’s largest technology companies and leading research organisations such as Universities.

“I am delighted with the progress GenIP has made since its successful start-up in February, followed by the acquisition of Invention Evaluator and Vortechs in June, and our listing in October 2024,” said Lord David Willetts, Chairman of GenIP.

“The Company is now well-positioned to achieve commercial success and expand its global footprint by leveraging our AI-enhanced solutions within the technology transfer market.”

GenIP recently announced a $350,000 order from a Saudi Arabian client and a $65,000 order from a Singapore-based research institution, demonstrating a sharp change in order levels from the early months as a listed company.

Wood Group shares tumble with takeover deal hanging by a thread

Wood Group shares plummeted on Monday after the energy services and engineering firm announced damaging findings from a review of its finances. The findings cast doubt over whether Sidara’s takeover deal will go ahead.

Wood Group shares were 30% lower at the time of writing.

Deloitte’s review of the company’s financials ‘identified material weaknesses and failures in the Group’s financial culture within the Projects business unit and engagement between Group Finance and Projects’.

As a result, Wood Group said the P&L and balance for the past three years would be adjusted, and EBITDA would also be revised.

“The situation continues to deteriorate at energy services business Wood Group which is damaging its credibility not just with investors but crucially potential customers too and its current suitor, Sidara,” said Russ Mould, investment director at AJ Bell.

“The deadline for Sidara to formalise a takeover deal has been pushed to 17 April but whether the latest revelations cause a rethink for the Dubai-based group or complications in the timetable remains to be seen.”

“While the issues revealed in a draft review of the business mainly relate to historical performance at its Projects business unit and do not relate to cash flow, they raise questions of culture given the failure to maintain robust accounting standards. The shares now face a suspension while historic accounts are restated.”

Investors who bought into the stock in the hope of a takeover deal now face a nervy wait for any update on the talks between Wood Group and Sidara. Dubai-based Sidara may be inclined to hold off making a move now to see what the fallout for Wood Group will be – and ultimately if they’re able to secure the group at a lower price.

Wood Group’s shares will be suspended from 30th April if the company does not publish FY24 accounts by 30th April. This is expected to be the case.

AIM movers: Mirriad Advertising partnership and Bioventix forecast cut

0

Mirriad Advertising (LON: MIRI) is partnering with media company Group Black, which will provide enhanced brand integration and engagement within the partner’s content slate. The two companies are assessing content to identify opportunities. The shar eprice jumped 58% to 0.395p.

Insurance premium finance provider Orchard Funding (LON: ORCH) reported an improvement in pre-tax profit from £1.08m to £2.1m. Impairment provisions fell from £490,000 to £60,000. Average income earning assets grew 9% to £67.9m. There is an interim dividend of 1p/share plus a special dividend of 1p/share. The company is sceptical about AIM, but it has not current plans to leave. The share price improved 15.8% to 33p.

Detergents and consumer products additives supplier Itaconix (LON: ITX) reported 2024 revenues down from $7.9m to $6.5m because of the loss of low margin business and the loss rose by 50% to $1.8m. However, Itaconix should return to growth this year and Canaccord Genuity has reduced its 2025 loss forecast from $1.1m to $900,000, thanks to improved gross margin, and expects break even in 2026. Itaconix has enough cash to achieve this. The share price rose 12.5% to 126p.

Drug delivery developer CRISM Therapeutics (LON: CRTX) has been working with the Medicines and Healthcare products Regulatory Agency (MHRA) to design the first in-human trial of ChemoSeed in patients with high grade glioma. Advice from the MHRA confirms further preclinical toxicology studies are not required, which saves £400,000, as well as recommending improvements to the trial plans. CRISM is on course to begin clinical trials by the end of 2025.  The share price increased 10.5% to 10.5p.

FALLERS

Catalyst Media Group (LON: CMX), which has a 20.5% of horse racing broadcaster Sports Information Services, fell into loss in the six months to December 2024. SIS paid a dividend of £630,000 to Catalyst Media during the period. NAV fell from 151.6p/share to 147.3p/share by the end of 2024, including cash of £1.1m, and a 4p/share dividend has subsequently been paid, which cost £840,000. SIS says that its profit in the year to March 2025 will be lower because of additional costs and delays in new non-racing business. The share price slumped 21.6% to 40p.

Bank note authentication technology Spectra Systems (LON: SPSC) reported 2024 figures that were ahead of forecast, but there was profit taking in the shares, which slid 18% to 205p. Revenues were 142% higher at $49.2m and pre-tax profit jumped from $8.2m to $12.1m. The 2025 pre-tax profit forecast has been trimmed, but it is still $25m, although a fall to $19.9m is expected in 2026.

Andrada Mining Ltd (LON: ATM) reported higher costs than expected in its trading statement for the period to February 2025. It says 2025 C1 costs were $21,023/tonne of contained tin compared with guidance of $17,000-$21,000/tonne. The C2 costs were at the top end of guidance. The share price is 12.4% lower at 3.05p.

Antibodies developer Bioventix (LON: BVXP) released flat interim revenues of £6.73m, while pre-tax profit was 4% lower at £5.1m. The company’s markets are maturing, but there are potential growth opportunities. Cavendish reduced its full year pre-tax profit forecast by 11% to £10.3m, down from £10.9m the previous year, The share price fell 10% to 2475p.